Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002015807 | SCV002297072 | benign | not provided | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699634 | SCV005202873 | uncertain significance | not specified | 2024-07-24 | criteria provided, single submitter | clinical testing | Variant summary: MTOR c.5462G>C (p.Ser1821Thr) results in a conservative amino acid change located in the PIK-related kinase, FAT (IPR003151) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 240366 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.5462G>C in individuals affected with Smith-Kingsmore Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1500643). Based on the evidence outlined above, the variant was classified as uncertain significance. |